Evidence map›Paper›PMID 27672238›Full record

ArticleDisease markers

TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis.

Fang Liu, Yuan He, Qinghua Cao, Ni Liu, Wenhui Zhang

Open access · hybridAbstract read
In one paragraph

Article in Disease markers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Oncology letters · 2020
    Article
  11. Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma.Asian Pacific journal of cancer prevention : APJCP · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.Journal of experimental & clinical cancer research : CR · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fang LiuDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0002-5526-4535
Yuan HeState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Qinghua CaoDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0002-1405-040X
Ni LiuDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Wenhui ZhangDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Sun Yat-sen University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27672238
PMCPMC5031846
OpenAlexW2509704893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.